6/26/2025

SFM, ADBE, GE, and RMD stand out as GARP stocks blending solid growth potential with reasonable valuations for smart returns.

Source: Yahoo

6/25/2025

ResMed (RMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Source: Yahoo

6/25/2025

The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. SFM, ADBE, GE and RMD are some such stocks.

Source: Yahoo

6/20/2025

ResMed Inc. stock rises Friday, outperforms market

Source: MarketWatch

6/19/2025

RESMED INC. COMPLIANCE, PRIVACY AND QUALITY COMMITTEE CHARTER The ResMed Inc. Board of Directors adopted this amended Compliance, Privacy and Quality Committee Charter...

Source: Finnhub

6/18/2025

ResMed’s first quarter results were met with a strong market response, reflecting in-line revenue and profit performance alongside notable margin expansion. Management credited manufacturing and logistics efficiencies, positive product mix shifts, and sustained demand in both devices and masks as primary contributors to improved profitability. CEO Mick Farrell emphasized the benefits of investments in automation and U.S.-based production, stating, “Our results are a testament to the work that we

Source: Yahoo

6/13/2025

ResMed Inc. stock falls Friday, underperforms market

Source: MarketWatch

6/9/2025

ResMed dominates an enormous, underdiagnosed market with recurring revenue and digital health leadership. Read why RMD stock is a Strong Buy.

Source: SeekingAlpha

6/7/2025

Read here for weekly updates on Dividend Champions, Contenders & Challengers. Learn about dividend changes, ex-dividend dates and pay dates.

Source: SeekingAlpha

6/6/2025

ResMed Inc. stock rises Friday, still underperforms market

Source: MarketWatch

6/6/2025

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Source: Yahoo

6/5/2025

Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Insulet (NASDAQ:PODD) and its peers.

Source: Yahoo

6/4/2025

ResMed Inc. stock rises Wednesday, outperforms market

Source: MarketWatch

6/4/2025

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Source: Yahoo

6/3/2025

ResMed Inc. stock rises Tuesday, outperforms market

Source: MarketWatch

6/3/2025

Track 50 top dividend growth stocks with daily valuation updates. Discover upgrades like Ferrari & Accenture, outperforming SPY & SCHD in 2023.

Source: SeekingAlpha

6/3/2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Masimo (NASDAQ:MASI) and the rest of the patient monitoring stocks fared in Q1.

Source: Yahoo

6/2/2025

Discover my June 2025 Top 15 high-growth dividend stocks, offering a 1.34% yield, 22.82% growth rate, and 25% undervaluation.

Source: SeekingAlpha

6/2/2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by 13.2%. This performance was significantly worse than the S&P 500’s 2.4% decline.

Source: Yahoo

5/27/2025

ResMed Inc. stock rises Tuesday, still underperforms market

Source: MarketWatch